Cystatin C, Renal Function, and Cardiovascular Risk

  1. Pierre Delanaye, MD;
  2. Etienne Cavalier, MD; and
  3. Jean-Marie Krzesinski, MD, PhD
  1. From University of Liège, CHU Sart Tilman, B-9000 Liège, Belgium.

    TO THE EDITOR:

    We read with interest the article by Menon and colleagues (1) concerning cystatin C as a cardiovascular risk factor. We believe their paper considerably increases the quality of articles published on this topic, especially because glomerular filtration rate (GFR) was measured with a reference method.

    We have some comments. First, it is important to keep in mind that this study analyzes cystatin C as a cardiovascular risk factor. Because all the patients had chronic kidney disease (CKD) (GFR <55 mL/min per 1.73 m2), this …

    This 100-word excerpt has been provided in the absence of an abstract.

    | Table of Contents
    Most Read Most Read
    Most Commented Most Commented On
    Annals in the News Annals in the News
    Clinical Trials Clinical Trials
    Comparative Effectiveness Comparative Effectiveness
    Hospital Medicine Hospital Medicine
    • Advertisement
    • Advertisement